Purchases and Sales Made in Q4 2024 in Kal Vista Pharmaceuticals, Inc. (KALV)
This table provides information about the institutional ownership of Kal Vista Pharmaceuticals, Inc. (KALV) during Q4 2024. The information is specifically focused on institutions that hold shares of KalVista Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Birchview Capital, LP
Burlington, VT |
SELL
|
- |
-15K- 18.29% |
$121K - $188K
|
67K
$1.07M
|
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-15.5K- 40.45% |
$125K - $194K
|
22.8K
$363K
|
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-16.6K- 18.51% |
$135K - $208K
|
73.3K
$1.17M
|
|
|
Feb 11, 2025
Q4 2024
|
American Century Companies Inc
Kansas City, MO |
SELL
|
- |
-24.7K- 70.99% |
$199K - $308K
|
10.1K
$160K
|
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-52.5K- 29.38% |
$425K - $656K
|
126K
$2.01M
|
|
|
Feb 14, 2025
Q4 2024
|
Emerald Mutual Fund Advisers Trust
|
SELL
|
- |
-101K- 15.56% |
$819K - $1.27M
|
550K
$8.75M
|
|
|
Feb 14, 2025
Q4 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-1.12M- 78.87% |
$9.06M - $14M
|
300K
$4.78M
|